Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
[우선권]신규 쿠드라플라본 J 유도체 (가칭)
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 이경 | - |
| dc.contributor.author | 조정숙 | - |
| dc.contributor.author | 이창훈 | - |
| dc.date.accessioned | 2025-09-09T10:02:17Z | - |
| dc.date.available | 2025-09-09T10:02:17Z | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/61393 | - |
| dc.description.abstract | 1. Novel cudraisoflavone J analogs were designed and synthesized. 2. Compounds 13m and 24 extensively inhibited 6-OHDA- and rotenone-induced cell death. 3, 13m and 24 increased expression levels of HO-1 and Nrf2. 4. Nrf2/HO-1 pathway is mediated by phosphorylated ERK1/2, JNK, and Akt in PC12 cells. 5. 13m and 24 may be promising therapeutic candidates to prevent and/or treat PD. | - |
| dc.title | [우선권]신규 쿠드라플라본 J 유도체 (가칭) | - |
| dc.title.alternative | Novel cudraisoflavone J derivatives as potent neuroprotective agents for the treatment of Parkinson’s disease via the activation of Nrf2/HO-1 signaling | - |
| dc.type | Patent | - |
| dc.publisher.location | 대한민국 | - |
| dc.contributor.assignee | 동국대학교산학협력단 | - |
| dc.date.application | 2023-03-06 | - |
| dc.date.registration | 2025-04-21 | - |
| dc.type.iprs | 특허 | - |
| dc.identifier.patentRegistrationNumber | 10-2800007 | - |
| dc.identifier.patentApplicationNumber | 10-2023-0028860 | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Pharmacy > Department of Pharmacy > 4. Patents
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Lee, Chang Hoon
- College of Pharmacy (Department of Pharmacy)